Laboratory of Net Income
| LH Stock | USD 284.50 10.49 3.83% |
As of the 11th of February 2026, Laboratory secures the Mean Deviation of 1.03, risk adjusted performance of 0.126, and Downside Deviation of 1.08. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Laboratory, as well as the relationship between them.
Laboratory Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.0811 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 857.9 M | 523.2 M | |
| Net Income Applicable To Common Shares | 857.9 M | 669.3 M | |
| Net Income From Continuing Ops | 859.2 M | 876.9 M | |
| Net Income Per Share | 8.00 | 8.40 | |
| Net Income Per E B T | 0.70 | 0.43 |
Laboratory | Net Income | Build AI portfolio with Laboratory Stock |
The Net Income trend for Laboratory of offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Laboratory is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Laboratory's Net Income Growth Pattern
Below is the plot of the Net Income of Laboratory of over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Laboratory financial statement analysis. It represents the amount of money remaining after all of Laboratory of operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Laboratory's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 746 M | 10 Years Trend |
|
Net Income |
| Timeline |
Laboratory Net Income Regression Statistics
| Arithmetic Mean | 830,924,483 | |
| Geometric Mean | 658,897,329 | |
| Coefficient Of Variation | 65.20 | |
| Mean Deviation | 380,794,482 | |
| Median | 732,100,000 | |
| Standard Deviation | 541,789,320 | |
| Sample Variance | 293535.7T | |
| Range | 2.3B | |
| R-Value | 0.37 | |
| Mean Square Error | 269439.9T | |
| R-Squared | 0.14 | |
| Significance | 0.14 | |
| Slope | 40,066,494 | |
| Total Sum of Squares | 4696570.7T |
Laboratory Net Income History
Other Fundumenentals of Laboratory
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Laboratory Net Income component correlations
Laboratory Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Laboratory is extremely important. It helps to project a fair market value of Laboratory Stock properly, considering its historical fundamentals such as Net Income. Since Laboratory's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Laboratory's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Laboratory's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Providers & Services market expansion? Will Laboratory introduce new products? Factors like these will boost the valuation of Laboratory. Expected growth trajectory for Laboratory significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.56 | Dividend Share 2.88 | Earnings Share 10.19 | Revenue Per Share | Quarterly Revenue Growth 0.086 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Laboratory's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Laboratory represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Laboratory's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Laboratory 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Laboratory's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Laboratory.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Laboratory on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Laboratory of or generate 0.0% return on investment in Laboratory over 90 days. Laboratory is related to or competes with Waters, Quest Diagnostics, Zimmer Biomet, West Pharmaceutical, Illumina, DexCom, and STERIS Plc. Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to... More
Laboratory Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Laboratory's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Laboratory of upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.08 | |||
| Information Ratio | 0.0834 | |||
| Maximum Drawdown | 5.89 | |||
| Value At Risk | (1.62) | |||
| Potential Upside | 2.85 |
Laboratory Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratory's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Laboratory's standard deviation. In reality, there are many statistical measures that can use Laboratory historical prices to predict the future Laboratory's volatility.| Risk Adjusted Performance | 0.126 | |||
| Jensen Alpha | 0.154 | |||
| Total Risk Alpha | 0.056 | |||
| Sortino Ratio | 0.1037 | |||
| Treynor Ratio | 0.3952 |
Laboratory February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.126 | |||
| Market Risk Adjusted Performance | 0.4052 | |||
| Mean Deviation | 1.03 | |||
| Semi Deviation | 0.8908 | |||
| Downside Deviation | 1.08 | |||
| Coefficient Of Variation | 656.63 | |||
| Standard Deviation | 1.34 | |||
| Variance | 1.81 | |||
| Information Ratio | 0.0834 | |||
| Jensen Alpha | 0.154 | |||
| Total Risk Alpha | 0.056 | |||
| Sortino Ratio | 0.1037 | |||
| Treynor Ratio | 0.3952 | |||
| Maximum Drawdown | 5.89 | |||
| Value At Risk | (1.62) | |||
| Potential Upside | 2.85 | |||
| Downside Variance | 1.17 | |||
| Semi Variance | 0.7935 | |||
| Expected Short fall | (1.23) | |||
| Skewness | 0.6373 | |||
| Kurtosis | 0.3528 |
Laboratory Backtested Returns
Laboratory is very steady at the moment. Laboratory has Sharpe Ratio of 0.0904, which conveys that the firm had a 0.0904 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Laboratory, which you can use to evaluate the volatility of the firm. Please verify Laboratory's Downside Deviation of 1.08, mean deviation of 1.03, and Risk Adjusted Performance of 0.126 to check out if the risk estimate we provide is consistent with the expected return of 0.11%. Laboratory has a performance score of 7 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.49, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Laboratory's returns are expected to increase less than the market. However, during the bear market, the loss of holding Laboratory is expected to be smaller as well. Laboratory right now secures a risk of 1.24%. Please verify Laboratory of potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to decide if Laboratory of will be following its current price movements.
Auto-correlation | -0.66 |
Very good reverse predictability
Laboratory of has very good reverse predictability. Overlapping area represents the amount of predictability between Laboratory time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Laboratory price movement. The serial correlation of -0.66 indicates that around 66.0% of current Laboratory price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.66 | |
| Spearman Rank Test | -0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 93.93 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Laboratory Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Laboratory of reported net income of 746 M. This is 118.59% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 30.65% lower than that of the firm.
Laboratory Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratory's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratory could also be used in its relative valuation, which is a method of valuing Laboratory by comparing valuation metrics of similar companies.Laboratory is currently under evaluation in net income category among its peers.
Laboratory ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Laboratory's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Laboratory's managers, analysts, and investors.Environmental | Governance | Social |
Laboratory Institutional Holders
Institutional Holdings refers to the ownership stake in Laboratory that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Laboratory's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Laboratory's value.| Shares | Fmr Inc | 2025-06-30 | 1.7 M | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.5 M | Amvescap Plc. | 2025-06-30 | 1.3 M | Jpmorgan Chase & Co | 2025-06-30 | 1.3 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 1.3 M | Alliancebernstein L.p. | 2025-06-30 | 1.1 M | Veritas Investment Partners (uk) Ltd. | 2025-06-30 | 1.1 M | Northern Trust Corp | 2025-06-30 | 1.1 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1 M | Vanguard Group Inc | 2025-06-30 | 9.9 M | Blackrock Inc | 2025-06-30 | 9.1 M |
Laboratory Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0463 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 28.65 B | ||||
| Shares Outstanding | 82.9 M | ||||
| Shares Owned By Insiders | 0.32 % | ||||
| Shares Owned By Institutions | 98.37 % | ||||
| Number Of Shares Shorted | 3.03 M | ||||
| Price To Earning | 12.69 X | ||||
| Price To Book | 2.61 X | ||||
| Price To Sales | 1.65 X | ||||
| Revenue | 13.01 B | ||||
| Gross Profit | 3.92 B | ||||
| EBITDA | 1.81 B | ||||
| Net Income | 746 M | ||||
| Cash And Equivalents | 1.52 B | ||||
| Cash Per Share | 4.63 X | ||||
| Total Debt | 7.27 B | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 1.73 X | ||||
| Book Value Per Share | 104.78 X | ||||
| Cash Flow From Operations | 1.59 B | ||||
| Short Ratio | 4.22 X | ||||
| Earnings Per Share | 10.19 X | ||||
| Price To Earnings To Growth | 2.01 X | ||||
| Target Price | 300.18 | ||||
| Number Of Employees | 70 K | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 22.77 B | ||||
| Total Asset | 18.38 B | ||||
| Retained Earnings | 8.3 B | ||||
| Working Capital | 1.48 B | ||||
| Current Asset | 585.1 M | ||||
| Current Liabilities | 226.4 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 18.38 B | ||||
| Last Dividend Paid | 2.88 |
About Laboratory Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratory of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is there potential for Health Care Providers & Services market expansion? Will Laboratory introduce new products? Factors like these will boost the valuation of Laboratory. Expected growth trajectory for Laboratory significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.56 | Dividend Share 2.88 | Earnings Share 10.19 | Revenue Per Share | Quarterly Revenue Growth 0.086 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Laboratory's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Laboratory represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Laboratory's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.